Align Technology, Inc. vs ArcelorMittal SA — how do they compare? Align Technology, Inc. trades at $170.21 (market cap $12.29B), while ArcelorMittal SA trades at $74.62 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 4.5× Align Technology, Inc.'s market cap, and ArcelorMittal SA pays a 0.81% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | MT | |
|---|---|---|
Market Cap | $12.29B | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $197.51 | $75.35 |
52-Week Low | $124.88 | $32.44 |
Enterprise Value | $11.30B | $65.45B |
Dividend Yield | — | 0.81% |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $176.04, up 1.37% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported record Q2 2026 revenue of $1.06 billion, driven by strong clear aligner volume growth. Analyst sentiment is positive, with 73% recommending buy, and institutional activity shows mixed positioning amid strategic initiatives like board changes and patent wins in China.
The outlook remains favorable due to solid fundamentals and international expansion, but risks include competitive pressures in digital dentistry and reliance on North American market stability. Earnings growth and margin improvements are key catalysts, though valuation multiples near five-year lows suggest potential upside if execution continues.
ArcelorMittal (MT) trades at $73.90, up 0.83% with bullish technical signals and strong institutional support. The stock shows improving fundamentals with Q2 2026 revenue growth despite an earnings miss, while maintaining stable dividends. Recent news highlights strategic partnerships and European business recovery prospects.
Outlook remains cautiously optimistic with 50% analyst buy ratings, though risks include cyclical steel demand and margin pressures. The current P/E of 30.97 appears elevated relative to historical norms, requiring sustained earnings growth to justify valuation.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →